Whilst hypoxia up regulated expression in A498 (RCC) by 1.8-fold, bevacizumab treatment does not appear to strongly regulate VEGFR1 in the other VEGFR1-expressing cell lines. This evidence concerns the gene FLT1 and renal cell carcinoma.